Adderall News and Research

RSS
Adderall (dextroamphetamine-amphetamine) is a combination of two synthetic agents with central nervous system stimulant activity. Both agents are non-catecholamine, sympathomimetic agents that elevate blood pressure and cause bronchodilation. These agents are commonly abused psychostimulant drugs that induce psychologic dependence manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. Tolerance to various effects develops unequally, so that tachycardia and enhanced alertness diminish while psychotoxic effects (hallucinations and delusions) may occur.
Researchers explain why ADHD continues to affect many adults

Researchers explain why ADHD continues to affect many adults

Misuse of prescription drugs common among U.S. college students

Misuse of prescription drugs common among U.S. college students

Shire enters into agreement with Sanquin for CINRYZE

Shire enters into agreement with Sanquin for CINRYZE

Shire acquires Foresight Biotherapeutics for $300 million

Shire acquires Foresight Biotherapeutics for $300 million

Teens start misusing ADHD drugs and other stimulants earlier than you might think

Teens start misusing ADHD drugs and other stimulants earlier than you might think

Phase 2 IMAGO trial of SHP625 fails to meet primary endpoints in pediatric patients with ALGS

Phase 2 IMAGO trial of SHP625 fails to meet primary endpoints in pediatric patients with ALGS

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Physicians urge households to add 'clean my medicine cabinet' to Spring cleaning chores list

Physicians urge households to add 'clean my medicine cabinet' to Spring cleaning chores list

Shire announces acquisition of Meritage Pharma

Shire announces acquisition of Meritage Pharma

Shire announces completion of NPS Pharma acquisition

Shire announces completion of NPS Pharma acquisition

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

Shire announces FDA approval of Vyvanse Capsules for binge eating disorder

University of Copenhagen researchers move closer to developing antidote against cocaine addiction

University of Copenhagen researchers move closer to developing antidote against cocaine addiction

National survey shows decrease in alcohol, cigarette and illicit drug use among U.S. teens

National survey shows decrease in alcohol, cigarette and illicit drug use among U.S. teens

Mice may hold clues in development of ADHD, autism and bipolar disorder

Mice may hold clues in development of ADHD, autism and bipolar disorder

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Shire, ArmaGen partner to develop AGT-182 drug for treatment of Hunter syndrome

Viewpoints: Wheaton injunction muddies court's ruling on contraceptives; Boston hospital merger problems; advice for new VA chief

Viewpoints: Wheaton injunction muddies court's ruling on contraceptives; Boston hospital merger problems; advice for new VA chief

10,000 toddlers receive medication for ADHD, shows report

10,000 toddlers receive medication for ADHD, shows report

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Research findings point to potential biomarkers for early detection of at-risk youth

Research findings point to potential biomarkers for early detection of at-risk youth